ICYMI: UK Paying Less for Cancer Drugs Than Other EU Countries

According to Pharmatimes.com, “The UK is paying less for new cancer drugs than most other countries in Europe, a new report has found.  The study in The Lancet Oncology also reveals that the prices of such drugs vary widely – from 28 percent to 388 percent –...

Pfizer, Allergan Combining in $160 Billion Deal

According to the Chicago Tribune, “Pfizer and Allergan will join in a $160 billion deal to create the world’s largest drugmaker. The transaction is valued at $363.63 per Allergan share.”  Click here for more details on this acquisition:...